Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
5.10
-0.16 (-3.04%)
At close: Mar 28, 2025, 4:00 PM
5.12
+0.02 (0.41%)
After-hours: Mar 28, 2025, 7:51 PM EDT

Monte Rosa Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Monte Rosa Therapeutics stock have an average target of 14.33, with a low estimate of 10 and a high estimate of 17. The average target predicts an increase of 180.98% from the current stock price of 5.10.

Analyst Consensus: Buy
Target Low Average Median High
Price $10 $14.33 $16 $17
Change +96.08% +180.98% +213.73% +233.33%

Analyst Ratings

The average analyst rating for Monte Rosa Therapeutics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 000000
Buy 442222
Hold 001111
Sell 000000
Strong Sell 000000
Total 443333

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wells Fargo
Wells Fargo
Hold
Maintains
$11$10
Hold Maintains $11$10 +96.08% Mar 21, 2025
Wedbush
Wedbush
Buy
Maintains
$15$17
Buy Maintains $15$17 +233.33% Mar 21, 2025
Wells Fargo
Wells Fargo
Hold
Downgrades
$14$11
Hold Downgrades $14$11 +115.69% Dec 19, 2024
Wedbush
Wedbush
Buy
Reiterates
$11
Buy Reiterates $11 +115.69% Sep 12, 2024
Wells Fargo
Wells Fargo
Buy
Maintains
$18$17
Buy Maintains $18$17 +233.33% Aug 12, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
15.56M
from 75.62M
Decreased by -79.43%
Revenue Next Year
15.91M
from 15.56M
Increased by 2.30%
EPS This Year
-1.53
from -0.98
EPS Next Year
-1.64
from -1.53
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
----75.62M15.56M15.91M135.11M
Revenue Growth
------79.43%2.30%749.11%
EPS
-23.65-2.96-2.30-2.63-0.98-1.53-1.64-1.48
EPS Growth
--------
Forward PE
--------
No. Analysts -----10108
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High 54.6M 81.9M 368.6M
Avg 15.6M 15.9M 135.1M
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High
-27.8%
426.5%
2,216.2%
Avg
-79.4%
2.3%
749.1%
Low - - -

EPS Forecast

EPS 20252026202720282029
High -0.72 -0.70 -0.30
Avg -1.53 -1.64 -1.48
Low -1.97 -2.29 -2.55

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.